Li-da Zhang

A preliminary study of plasma cyclase-associated protein 2 as a novel biomarker for early stage and alpha-fetoprotein negative hepatocellular carcinoma patients.

T. Zheng, Yu-xiu Yang, S. Ding, 2015, Clinics and research in hepatology and gastroenterology.

Silencing circSLAMF6 represses cell glycolysis, migration, and invasion by regulating the miR-204-5p/MYH9 axis in gastric cancer under hypoxia

Songze Ding, Li-da Zhang, Xinhui Fang, 2020, Bioscience reports.

Thymoquinone chemosensitizes colon cancer cells through inhibition of NF-κB.

Li-da Zhang, Yuxiu Yang, Yangqiu Bai, 2016, Oncology letters.

Tanshinone IIA enhances chemosensitivity of colon cancer cells by suppressing nuclear factor-κB.

Li-da Zhang, Xinhui Fang, Yuxiu Yang, 2016, Experimental and therapeutic medicine.

Helicobacter pylori infection‐induced H3Ser10 phosphorylation in stepwise gastric carcinogenesis and its clinical implications

S. Ding, L. Kong, S. Han, 2018, Helicobacter.

Plasma minichromosome maintenance complex component 6 is a novel biomarker for hepatocellular carcinoma patients

T. Zheng, S. Ding, Shuangyin Han, 2014, Hepatology research : the official journal of the Japan Society of Hepatology.

Plasma CD24 as a novel useful biomarker in differentiating hepatocellular carcinoma patients from normal individuals.

Shuangyin Han, Li-da Zhang, Xinhui Fang, 2013, Hepato-Gastroenterology.

FAT 10 protein as a potential serological marker in the diagnosis of hepatocellullar carcinoma.

S. Ding, Si-Yu Zhang, Yu-xiu Yang, 2017, Clinics and research in hepatology and gastroenterology.